Relationship of the AKR1B1 rs759853 and rs9640883 with the development of diabetic retinopathy

S.Iu. Mogilevskyy1, Dr Sc (Med), Prof.

O. V. Bushuieva2, Assistant

S.V. Ziablitsev3, Dr Sc (Med), Prof.

L.V. Natrus3, Dr Sc (Med), Prof.

1Shupik National Medical Academy of Postgraduate Education

2Danylo Halytsky Lviv National Medical University

3Bohomolets National Medical University

Kyiv, Lviv, Ukraine

E-mail: sergey.mogilevskyy@gmail.com


Background: In type 2 diabetes mellitus (DM2), hyperglycemia activates the polyol pathway of glucose metabolism, resulting in accumulation of sorbitol and fructose. Polymorphism of aldose reductase (a key enzyme of the poliol pathway) gene (AKR1B1) influences the activity of the polyol pathway and might be associated with the development of diabetic retinopathy (DR).

Purpose: To identify any association of the polymorphisms influencing the activity of aldose reductase gene (rs759853 and rs9640883 of AKR1B1) with DR in the Ukrainian population.

Materials and Methods: In total, 311 individuals were involved in the study. Group 1 (control group) was composed of 107 ophthalmologically normal subjects. Group 2 contained 76 patients with stage 1 DR (i.e., showing no fundus changes). Group 3 consisted of 64 patients diagnosed with non-proliferative DR (NPDR), and Group 4 was composed of 64 patients diagnosed with proliferative DR (PDR). The TaqMan Mutation Detection Assays were used to analyze polymorphic DNA loci in a Real-Time PCR System 7500.

Results and Discussion: In Ukrainian population, rs759853 and rs9640883 of AKR1B1 were associated with the development of DR. The mutant A allele and AA genotype at the rs759853 increased the odds (OR=2.8 and OR=5.2, respectively; р<0.001) of developing DR. In addition, the ancestral G allele and the homozygous G/G status at the rs9640883 increased the odds (OR=2.6 and OR=3.0, respectively; р<0.001) of developing DR. The presence of risk alleles had a negative effect on the development of DR in DM2. The AKR1B1 rs759853 and rs9640883 had no effect on the development of PDR. Importance of the polymorphisms for the development of DR was demonstrated by dispersion analysis (rs759853: F = 18.9, p < 0.001; rs9640883: F = 6.9, p = 0.001).

Conclusion: The frequency of the ancestral G allele of the AKR1B1 rs759853 significantly decreased, whereas that of the mutant A allele increased with increased severity of pathological process in DR.  The frequency of the ancestral GG genotype of the AKR1B1 rs9640883 was significantly elevated, whereas that of the heterozygous GA genotype was decreased, and minor homozygous AA genotype was absent in diabetes patients with DR.

Key words: diabetic retinopathy, AKR1B1, rs759853, rs9640883      


1.   Abhary S, Hewitt AW, Burdon KP, Craid JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009; 58(9):2137-47
Crossref   Pubmed

2.   Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445:881-5
Crossref   Pubmed

3.   Hallman DM, Huber JC, Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005;28(5);1163-8
Crossref   Pubmed

4.   Liew G, Klein R, Wong TY. The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin. 2009;49(2):35-52
Crossref   Pubmed

5.   Pan’kiv VI. [Workshop No. 132. Diabetes mellitus: Diagnostic criteria, etiology and pathogenesis]. IEJ. 2013;8:53-64 Ukrainian

6.   Cho H, Sobrin L. Genetics of diabetic retinopathy. Curr Diab Rep. 2014;14(8):515.
Crossref   Pubmed

7.   Hietala K, Forsblom C, Summanen P, Groop PH. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57:2176-80
Crossref   Pubmed

8.   Zhang X, Gao Y, Zhou Z, et al. Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol. 2010; 20(5):911-8
Crossref   Pubmed

9.   Suzen S, Buyukbingol E. Recent studies of aldose reductase enzyme inhibition for diabetic complications. Curr Med Chem. 2003;10(15):1329-52
Crossref   Pubmed